Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucyna Matusewicz

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cancers|November 4, 2018
Immunoliposomes with Simvastatin as a Potential Therapeutic in Treatment of Breast Cancer Cells Overexpressing HER2-An In Vitro StudyLucyna Matusewicz, Joanna Podkalicka, Aleksander F Sikorski
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 15, 2020
Attempts to use statins in cancer therapy: An updateLucyna Matusewicz, Aleksander Czogalla, Aleksander F Sikorski
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 24, 2015
The effect of statins on cancer cells--reviewLucyna Matusewicz, Justyna Meissner, Monika Toporkiewicz, et al.
Postepy Higieny I Medycyny Doswiadczalnej (Online)|April 28, 2016
[Liposomes as non-viral carriers for genetic drugs]Justyna M Meissner, Monika Toporkiewicz, Lucyna Matusewicz, et al.
International Journal of Nanomedicine|March 4, 2015
Toward a magic or imaginary bullet? Ligands for drug targeting to cancer cells: principles, hopes, and challengesMonika Toporkiewicz, Justyna Meissner, Lucyna Matusewicz, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 21, 2015
Novel antisense therapeutics delivery systems: In vitro and in vivo studies of liposomes targeted with anti-CD20 antibodyJustyna M Meissner, Monika Toporkiewicz, Aleksander Czogalla, et al.
Cellular & Molecular Biology Letters|June 1, 2022
COVID-19 therapies: do we see substantial progress?Lucyna Matusewicz, Marlena Golec, Aleksander Czogalla, et al.
International Journal of Molecular Sciences|February 26, 2025
Development of Stable, Maleimide-Functionalized Peptidoliposomes Against SARS-CoV-2Olga Michel, Aleksandra Kaczorowska, Lucyna Matusewicz, et al.
International Journal of Pharmaceutics|August 11, 2019
EGFR-targeted immunoliposomes as a selective delivery system of simvastatin, with potential use in treatment of triple-negative breast cancersLucyna Matusewicz, Beata Filip-Psurska, Mateusz Psurski, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancers|November 4, 2018
Immunoliposomes with Simvastatin as a Potential Therapeutic in Treatment of Breast Cancer Cells Overexpressing HER2-An In Vitro StudyLucyna Matusewicz, Joanna Podkalicka, Aleksander F Sikorski
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 15, 2020
Attempts to use statins in cancer therapy: An updateLucyna Matusewicz, Aleksander Czogalla, Aleksander F Sikorski
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 24, 2015
The effect of statins on cancer cells--reviewLucyna Matusewicz, Justyna Meissner, Monika Toporkiewicz, et al.
Postepy Higieny I Medycyny Doswiadczalnej (Online)|April 28, 2016
[Liposomes as non-viral carriers for genetic drugs]Justyna M Meissner, Monika Toporkiewicz, Lucyna Matusewicz, et al.
International Journal of Nanomedicine|March 4, 2015
Toward a magic or imaginary bullet? Ligands for drug targeting to cancer cells: principles, hopes, and challengesMonika Toporkiewicz, Justyna Meissner, Lucyna Matusewicz, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 21, 2015
Novel antisense therapeutics delivery systems: In vitro and in vivo studies of liposomes targeted with anti-CD20 antibodyJustyna M Meissner, Monika Toporkiewicz, Aleksander Czogalla, et al.
Cellular & Molecular Biology Letters|June 1, 2022
COVID-19 therapies: do we see substantial progress?Lucyna Matusewicz, Marlena Golec, Aleksander Czogalla, et al.
International Journal of Molecular Sciences|February 26, 2025
Development of Stable, Maleimide-Functionalized Peptidoliposomes Against SARS-CoV-2Olga Michel, Aleksandra Kaczorowska, Lucyna Matusewicz, et al.
International Journal of Pharmaceutics|August 11, 2019
EGFR-targeted immunoliposomes as a selective delivery system of simvastatin, with potential use in treatment of triple-negative breast cancersLucyna Matusewicz, Beata Filip-Psurska, Mateusz Psurski, et al.
Pageof 1